| Symbol |
Name |
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADORA2B
|
adenosine A2b receptor
|
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3
|
|
AQP5
|
aquaporin 5
|
|
ATF2
|
activating transcription factor 2
|
|
BDKRB1
|
bradykinin receptor B1
|
|
BDKRB2
|
bradykinin receptor B2
|
|
C3
|
complement component 3
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
|
CCL17
|
chemokine (C-C motif) ligand 17
|
|
CCL18
|
chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated)
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL22
|
chemokine (C-C motif) ligand 22
|
|
CCL26
|
chemokine (C-C motif) ligand 26
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CD14
|
CD14 molecule
|
|
CD200
|
CD200 molecule
|
|
CD28
|
CD28 molecule
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CLCA1
|
chloride channel accessory 1
|
|
CLEC16A
|
C-type lectin domain family 16, member A
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
CRLF2
|
cytokine receptor-like factor 2
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CTGF
|
connective tissue growth factor
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
|
CYSLTR1
|
cysteinyl leukotriene receptor 1
|
|
DUOXA2
|
dual oxidase maturation factor 2
|
|
E2F6
|
E2F transcription factor 6
|
|
EGFR
|
epidermal growth factor receptor
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
FLG
|
filaggrin
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FOXJ1
|
forkhead box J1
|
|
FUCA1
|
fucosidase, alpha-L- 1, tissue
|
|
FUCA2
|
fucosidase, alpha-L- 2, plasma
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA3
|
GATA binding protein 3
|
|
GCNT1
|
glucosaminyl (N-acetyl) transferase 1, core 2
|
|
HBEGF
|
heparin-binding EGF-like growth factor
|
|
ICOSLG
|
inducible T-cell co-stimulator ligand
|
|
IFNG
|
interferon, gamma
|
|
IFNL1
|
interferon, lambda 1
|
|
IFT54
|
intraflagellar transport 54
|
|
IGES
|
immunoglobulin E concentration, serum
|
|
IGHE
|
immunoglobulin heavy constant epsilon
|
|
IL10
|
interleukin 10
|
|
IL12A
|
interleukin 12A
|
|
IL12B
|
interleukin 12B
|
|
IL13
|
interleukin 13
|
|
IL13RA1
|
interleukin 13 receptor, alpha 1
|
|
IL13RA2
|
interleukin 13 receptor, alpha 2
|
|
IL15
|
interleukin 15
|
|
IL16
|
interleukin 16
|
|
IL17A
|
interleukin 17A
|
|
IL17C
|
interleukin 17C
|
|
IL19
|
interleukin 19
|
|
IL2
|
interleukin 2
|
|
IL22
|
interleukin 22
|
|
IL25
|
interleukin 25
|
|
IL27
|
interleukin 27
|
|
IL2RG
|
interleukin 2 receptor, gamma
|
|
IL3
|
interleukin 3
|
|
IL31
|
interleukin 31
|
|
IL33
|
interleukin 33
|
|
IL33R
|
interleukin 33 receptor
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
IL5
|
interleukin 5
|
|
IL6
|
interleukin 6
|
|
IL7
|
interleukin 7
|
|
IL9
|
interleukin 9
|
|
ILF2
|
interleukin enhancer binding factor 2
|
|
ILF3
|
interleukin enhancer binding factor 3, 90kDa
|
|
IRS2
|
insulin receptor substrate 2
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
IVL
|
involucrin
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
KCNN4
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4
|
|
KLK7
|
kallikrein-related peptidase 7
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
LIF
|
leukemia inhibitory factor
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MCAM
|
melanoma cell adhesion molecule
|
|
MIR155
|
microRNA 155
|
|
MIRLET7A1
|
microRNA let-7a-1
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MUC2
|
mucin 2, oligomeric mucus/gel-forming
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
|
|
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
OPRM1
|
opioid receptor, mu 1
|
|
P2RY6
|
pyrimidinergic receptor P2Y, G-protein coupled, 6
|
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PLD1
|
phospholipase D1, phosphatidylcholine-specific
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PRKCD
|
protein kinase C, delta
|
|
PTGDR2
|
prostaglandin D2 receptor 2
|
|
PTGES
|
prostaglandin E synthase
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
RASGRP4
|
RAS guanyl releasing protein 4
|
|
S100A8
|
S100 calcium binding protein A8
|
|
SPDEF
|
SAM pointed domain containing ETS transcription factor
|
|
SPINK5
|
serine peptidase inhibitor, Kazal type 5
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
SUMF2
|
sulfatase modifying factor 2
|
|
TBX21
|
T-box 21
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB2
|
transforming growth factor, beta 2
|
|
TLR2
|
toll-like receptor 2
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFSF4
|
tumor necrosis factor (ligand) superfamily, member 4
|
|
TPT1
|
tumor protein, translationally-controlled 1
|
|
TSLP
|
thymic stromal lymphopoietin
|
|
TYK2
|
tyrosine kinase 2
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
XRCC6
|
X-ray repair complementing defective repair in Chinese hamster cells 6
|